These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
179 related items for PubMed ID: 2258157
1. Preventive therapy of first gastrointestinal bleeding in patients with cirrhosis: results of a controlled trial comparing propranolol, endoscopic sclerotherapy and placebo. Andreani T, Poupon RE, Balkau BJ, Trinchet JC, Grange JD, Peigney N, Beaugrand M, Poupon R. Hepatology; 1990 Dec; 12(6):1413-9. PubMed ID: 2258157 [Abstract] [Full Text] [Related]
4. [Prevention of recurrent hemorrhage in patients with cirrhosis. Results of a controlled trial of propranolol versus endoscopic sclerotherapy]. Martin T, Taupignon A, Lavignolle A, Perrin D, Le Bodic L. Gastroenterol Clin Biol; 1991 Dec; 15(11):833-7. PubMed ID: 1769473 [Abstract] [Full Text] [Related]
6. Propranolol in the prevention of recurrent upper gastrointestinal bleeding in patients with cirrhosis undergoing endoscopic sclerotherapy. A randomized controlled trial. Avgerinos A, Rekoumis G, Klonis C, Papadimitriou N, Gouma P, Pournaras S, Raptis S. J Hepatol; 1993 Sep; 19(2):301-11. PubMed ID: 8301065 [Abstract] [Full Text] [Related]
7. [Endoscopic sclerotherapy versus propranolol after hemorrhage caused by rupture of esophageal varices in patients with cirrhosis. Results of a 4-year randomized study]. Dollet JM, Champigneulle B, Patris A, Bigard MA, Gaucher P. Gastroenterol Clin Biol; 1988 Mar; 12(3):234-9. PubMed ID: 3259521 [Abstract] [Full Text] [Related]
8. Prevention of recurrent bleeding in cirrhotics with recent variceal hemorrhage: prospective, randomized comparison of propranolol and sclerotherapy. Fleig WE, Stange EF, Hunecke R, Schönborn W, Hurler U, Rainer K, Gaus W, Ditschuneit H. Hepatology; 1987 Mar; 7(2):355-61. PubMed ID: 3549507 [Abstract] [Full Text] [Related]
12. A controlled trial of oral propranolol compared with injection sclerotherapy for the long-term management of variceal bleeding. Westaby D, Polson RJ, Gimson AE, Hayes PC, Hayllar K, Williams R. Hepatology; 1990 Mar; 11(3):353-9. PubMed ID: 2179096 [Abstract] [Full Text] [Related]
13. Propranolol in the prevention of first upper gastrointestinal tract hemorrhage in patients with cirrhosis of the liver and esophageal varices. Pascal JP, Cales P. N Engl J Med; 1987 Oct 01; 317(14):856-61. PubMed ID: 3306385 [Abstract] [Full Text] [Related]
14. Prospective controlled trial of elective endoscopic sclerotherapy in comparison with percutaneous transhepatic obliteration of esophageal varices in patients with nonalcoholic cirrhosis. Terabayashi H, Ohnishi K, Tsunoda T, Nakata H, Saito M, Tanaka H, Iida S, Nomura F, Okuda K. Gastroenterology; 1987 Dec 01; 93(6):1205-9. PubMed ID: 3315824 [Abstract] [Full Text] [Related]
20. Propranolol for prophylaxis of bleeding in cirrhotic patients with large varices: a multicenter, randomized clinical trial. The Italian Multicenter Project for Propranolol in Prevention of Bleeding. Hepatology; 1988 Dec 01; 8(1):1-5. PubMed ID: 2892771 [Abstract] [Full Text] [Related] Page: [Next] [New Search]